Antibiotic resistance in gonorrhea

From WikiMD's WELLNESSPEDIA

NeisseriaGonorrhoeae

Antibiotic resistance in gonorrhea

Antibiotic resistance in gonorrhea refers to the ability of the bacterium Neisseria gonorrhoeae to resist the effects of antibiotics that were once effective in treating infections caused by this pathogen. This resistance has become a significant public health concern globally.

Overview[edit]

Neisseria gonorrhoeae is the causative agent of gonorrhea, a common sexually transmitted infection (STI). Over the years, the bacterium has developed resistance to multiple classes of antibiotics, including penicillin, tetracycline, fluoroquinolones, and more recently, cephalosporins.

Mechanisms of Resistance[edit]

The mechanisms by which Neisseria gonorrhoeae develops antibiotic resistance include:

  • **Genetic mutations**: Changes in the bacterial DNA can lead to resistance.
  • **Horizontal gene transfer**: The bacterium can acquire resistance genes from other bacteria.
  • **Efflux pumps**: These proteins expel antibiotics from the bacterial cell.
  • **Enzymatic degradation**: The bacterium produces enzymes that inactivate antibiotics.

Current Treatment Challenges[edit]

The increasing resistance of Neisseria gonorrhoeae to antibiotics has made treatment more challenging. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have updated their treatment guidelines to recommend dual therapy with ceftriaxone and azithromycin as the first-line treatment. However, there are concerns about the emergence of strains resistant to these antibiotics as well.

Prevention and Control[edit]

Efforts to combat antibiotic resistance in gonorrhea include:

  • **Surveillance**: Monitoring the spread of resistant strains.
  • **Research**: Developing new antibiotics and alternative treatments.
  • **Public health initiatives**: Promoting safe sex practices and regular STI screenings.

Related Pages[edit]

See Also[edit]

References[edit]


External Links[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.